Open AccessCabozantinib enhances the response of NSCLC cells with wild-type EGFR to erlotinib and pharmacodynamic modeling of their sequential combinations
Author(s) -
Zhen-zhen Mou
Publication year - 2016
Publication title -
journal of chinese pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.138
H-Index - 12
ISSN - 1003-1057
DOI - 10.5246/jcps.2016.11.089
Subject(s) - erlotinib , cabozantinib , pharmacodynamics , pharmacology , medicine , oncology , cancer research , pharmacokinetics , epidermal growth factor receptor , cancer